Field Trip Health Closes $20.0 Million Bought Deal

Field Trip Health (CSE: FTRP) this morning announced the closing of its bought deal financing, raising gross proceeds of $20.0 million. The closing is notable, given that the placement took place at $4.50 per share, having been announced when the equity was trading at $5.00, while the equity yesterday closed at $3.83 per share.

The financing saw a total of 4.4 million units of the company sold, with each unit being comprised of one common share and one half of a common share purchase warrant. Each whole warrant is valid until July 5, 2022, and exercisable at a price of $5.60 per share. The warrants also contain an accelerator, providing for the forced acceleration of the warrant should the company trade over $9.00 for ten consecutive days on a volume weighted basis.

Proceeds from the offering are to be used for working capital and general corporate purposes.

Field Trip Health last traded at $3.70 on the CSE.


Information for this analysis was found via Sedar and Field Trip Health. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Field Trip Health To Launch Amsterdam Location Focused On Psychedelic Truffles

Field Trip Health (CSE: FTRP) is going to Amsterdam. The company announced this morning that...

Tuesday, November 17, 2020, 08:30:37 AM

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are...

Monday, June 14, 2021, 03:38:00 PM

Eight Capital Initiates Coverage On Field Trip Health With $10.20 Price Target

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes...

Friday, September 17, 2021, 10:59:00 AM

Field Trip Health Expands Bought Deal To $17.4 Million

As has become a trend within the psychedelics space, Field Trip Health (CSE: FTRP) this...

Thursday, December 10, 2020, 09:37:58 AM

Field Trip Health To Divide Into Two Separate Firms

Field Trip Health (TSX: FTRP) is set to be split into two separate firms. The...

Friday, April 29, 2022, 08:01:36 AM